Due date: October 28, 2021
NIA participates in the annual NIH SBIR contracts solicitation, which aims to spur development of specific R&D innovations that address key priorities. For 2022, NIA has requested proposals for three topics:
- NIH/NIA 004 - Improving Central Nervous System Gene Delivery Systems for Alzheimer’s Disease and Related Dementias Therapy Development: Improve gene delivery systems to overcome current challenges.
- Number of anticipated awards: 2 to 5.
- Budget (total costs, per award): Phase I: $500,000 for 12 months; Phase II: $2,500,000 for 2 years
- NIH/NIA 005 - Geroscience-Based Chronic Wound Treatment Product Development: Develop wound treatment that incorporates geroscience-based therapeutic modalities such as stem cell therapies, senolytics, inflammation modulators.
- Number of anticipated awards: 1 to 2
- Budget (total costs, per award): Phase I: $350,000 for 12 months; Phase II: $2,500,000 for 2 years (Phase II information is provided for informational purposes only, to assist Phase I offerors with their long-term strategic planning.)
- NIH/NIA 006 - The Development of Mechanism-Based Adult Stem Cell Treatments to Combat Aging Pathologies: Develop a stem cell-based therapeutic with a defined mechanistic understanding of how it promotes regeneration and/or rejuvenation of aging tissues.
- Number of anticipated awards: 1 to 2
- Budget (total costs, per award): Phase I: $350,000 for 12 months; Phase II: $2,000,000 for 2 years
